Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women

scientific article

Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CONTRACEPTION.2011.05.010
P932PMC publication ID3200533
P698PubMed publication ID22018136
P5875ResearchGate publication ID51740548

P50authorMatthew ReevesQ43128886
Eleanor Bimla SchwarzQ44395493
P2093author name stringTiffany Behringer
Beatrice A Chen
Brianna Rossiter
P2860cites workDisparities in rates of unintended pregnancy in the United States, 1994 and 2001Q28245779
Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001Q29391257
Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.Q33872578
Sexually transmitted diseases treatment guidelines, 2006.Q34554277
Economic analysis of contraceptives for womenQ35183917
Intrauterine devices and reproductive health: American women in feast and famineQ35781048
The levonorgestrel intrauterine system in nulliparous womenQ36832734
Intrauterine devices for adolescents: a systematic reviewQ37482553
IUDs and adolescents--an under-utilized opportunity for pregnancy preventionQ37629034
Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.Q37732949
Costs and net health effects of contraceptive methodsQ40508712
Time to pardon the IUD?Q43424783
Challenges in translating evidence to practice: the provision of intrauterine contraceptionQ45341409
Use of contraception in the United States: 1982-2008Q46869329
Unintended Pregnancy in the United StatesQ56814713
Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practiceQ77556382
Unintended pregnancy among U.S. adolescents: accounting for sexual activityQ84738337
P433issue5
P921main subjectlevonorgestrelQ416950
teenagerQ1492760
P304page(s)e5-e10
P577publication date2011-06-30
P1433published inContraceptionQ2995704
P1476titleDuration of use of a levonorgestrel IUS amongst nulliparous and adolescent women
P478volume84

Reverse relations

cites work (P2860)
Q34232112Association of age and parity with intrauterine device expulsion
Q33733137Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use
Q37982637Clinical practice: Contraception in adolescents
Q40053436Comparison of two cohorts of women who expulsed either a copper-intrauterine device or a levonorgestrel-releasing intrauterine system
Q57222604Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system
Q38114870Intrauterine device insertions: which variables matter?
Q40253354Let's talk about sex (again): advancing the conversation around long-acting reversible contraception for teenagers
Q34280810Long-acting reversible contraception for adolescents
Q45937153Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
Q36172363The safety of intrauterine devices among young women: a systematic review
Q40080442Uptake and continuation rates of the intrauterine system in a university student general practice population in the UK.
Q39032528Usage of the levonorgestrel-releasing intrauterine system (LNG-IUS) in adolescence: what is the evidence so far?